The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion in 2024 to USD ...

IgniteData, a leader in intelligent clinical trial data automation, today announced the final close of its oversubscribed Series A funding round. This close brings the total capital raised in the ...

Key opportunities in the AI clinical genomics interpretation market include the rising demand for precision medicine, wider adoption of AI-powered tools, advancements in predictive analytics, ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion from a ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality.

Abstract: Accurate identification of lung adenocarcinoma subtype is crucial for selecting appropriate treatment plans. However, challenges such as integrating diverse data, subtype similarities, and ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...

Most scientific data never fuel the discoveries they should. For every 100 datasets created, around 80 remain in the lab, 20 are shared but rarely reused, fewer than two meet FAIR standards, and only ...

Results from the Phase 1b dose escalation of the TheraPb Phase 1/2 trial are the first clinical data for a Lead-212 (212Pb)-based-PSMA radioligand therapy The abstract presents a favorable safety ...